Certara (HAM:700) Tax Provision: €-8.9 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HAM:700 Certara Inc HAM:700
65 GF Score
Price €5.97
GF Value €11.53
! 2 Warning Signs
View Full Analysis

What is Certara Tax Provision?

Certara HAM:700 -4.60% 65 Tax Provision is €-8.9 Mil as of Mar. 2026. GuruFocus rates HAM:700 with a GF Score™ of 65/100 and a GF Value™ of €11.53. The stock has 2 warning signs investors should review.

Certara's tax provision for the three months ended in Mar. 2026 was €-0.7 Mil. Its tax provision for the trailing twelve months (TTM) ended in Mar. 2026 was €-8.9 Mil.

Certara Tax Provision Historical Data

* Premium members only.

The historical data trend for Certara's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Certara Tax Provision Chart

Certara Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Tax Provision
Get a 7-Day Free Trial -8.75 -3.80 -0.20 4.90 -7.87

Certara Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 -7.13 1.53 -2.55 -0.71
HAM:700
65GF Score
Certara Inc HAM:700
Tax Provision is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Certara Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-8.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Provision →
What does a Tax Provision of €-8.9 Mil mean?
Certara (HAM:700) has a Tax Provision of €-8.9 Mil as of Mar. 2026. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on Certara and its competitors.
Is Certara's Tax Provision too high?
Certara's current Tax Provision is €-8.9 Mil. Overall, Certara has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does Certara's Tax Provision compare to TALK and GDRX?
Certara's Tax Provision of €-8.9 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Provision for a Healthcare Providers & Services company?
A good Tax Provision depends on the Healthcare Providers & Services industry context. However, Tax Provision should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Provision mean?
A high Tax Provision can signal that a stock is expensive relative to its fundamentals. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on Certara and its competitors. Certara's current Tax Provision is €-8.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Certara stock overvalued right now?
Certara (HAM:700) has a current Tax Provision of €-8.9 Mil. The stock's GF Value™ is €11.53, compared to a current price of €5.97 — trading 48.2% below its estimated fair value. The current Tax Provision is €-8.9 Mil. Certara's overall GF Score™ is 65/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Provision calculated?
Tax Provision is calculated from a company's financial statements. For Certara (HAM:700), the current Tax Provision is €-8.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Certara (HAM:700) Overvalued in 2026?

Based on GuruFocus' analysis, Certara stock appears to be undervalued. The current stock price of €5.97 is trading 48.2% below its estimated GF Value™ of €11.53.

Key valuation signals for HAM:700:

  • Tax Provision: €-8.9 Mil
  • GF Value™: €11.53 vs. price of €5.97 (48.2% below fair value)
  • GF Score™: 65/100 with 2 warning signs

No single metric tells the full story. See the HAM:700 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Certara Business Description

Other Exchanges CERT:USA
Address 4 Radnor Corporate Center, Suite 350, Radnor, PA, USA, 19087
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
65GF Score

Get the complete analysis for HAM:700

Tax Provision is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.97
Price
€11.53
GF Value